Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder.

Schreiber W, Lauer CJ, Krumrey K, Holsboer F, Krieg JC.

Neuropsychopharmacology. 1996 Jul;15(1):7-15.

2.

Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.

Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.

Psychoneuroendocrinology. 2012 Aug;37(8):1199-208. doi: 10.1016/j.psyneuen.2011.12.013. Epub 2012 Jan 23.

PMID:
22277728
3.

Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.

Schüle C, Baghai T, Zwanzger P, Minov C, Padberg F, Rupprecht R.

J Psychiatr Res. 2001 Jul-Aug;35(4):239-47.

PMID:
11578642
4.

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

Heuser I, Yassouridis A, Holsboer F.

J Psychiatr Res. 1994 Jul-Aug;28(4):341-56.

PMID:
7877114
5.

Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder.

Erhardt A, Ising M, Unschuld PG, Kern N, Lucae S, Pütz B, Uhr M, Binder EB, Holsboer F, Keck ME.

Neuropsychopharmacology. 2006 Nov;31(11):2515-22. Epub 2006 Jul 12.

6.

The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.

Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.

Biol Psychiatry. 1998 May 15;43(10):762-6.

PMID:
9606531
7.

Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.

Bschor T, Ising M, Erbe S, Winkelmann P, Ritter D, Uhr M, Lewitzka U.

J Psychiatr Res. 2012 Jan;46(1):111-7. doi: 10.1016/j.jpsychires.2011.09.020. Epub 2011 Oct 26.

PMID:
22030468
8.

Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.

Hikichi T, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Goto S, Matsushita H, Hanada H, Isogawa K, Nagayama H.

Neuropsychobiology. 2007;55(1):21-7. Epub 2007 Jun 8.

PMID:
17556849
10.
11.

Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test.

Thalén BE, Kjellman BF, Ljunggren JG, Akner G, Kågedal B, Wahlund B, Wetterberg L.

Acta Psychiatr Scand. 1993 Feb;87(2):133-40.

PMID:
8383420
12.

Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.

Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.

Neuropsychopharmacology. 2003 Dec;28(12):2169-78.

13.

Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease.

Hatzinger M, Z'Brun A, Hemmeter U, Seifritz E, Baumann F, Holsboer-Trachsler E, Heuser IJ.

Neurobiol Aging. 1995 Mar-Apr;16(2):205-9.

PMID:
7777138
14.

Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?

Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.

Biol Psychiatry. 2007 Jul 1;62(1):47-54. Epub 2006 Nov 21.

PMID:
17123470
16.

Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test.

Beck-Friis J, Ljunggren JG, Thorén M, von Rosen D, Kjellman BF, Wetterberg L.

Psychoneuroendocrinology. 1985;10(2):173-86.

PMID:
2994141
17.
18.

Adrenocorticotropic hormone, beta-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone.

Maes M, Meltzer H, Cosyns P, Calabrese J, D'Hondt P, Blockx P.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Dec;18(8):1273-92.

PMID:
7863016
20.

Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.

Horstmann S, Dose T, Lucae S, Kloiber S, Menke A, Hennings J, Spieler D, Uhr M, Holsboer F, Ising M.

Psychoneuroendocrinology. 2009 Feb;34(2):238-48. doi: 10.1016/j.psyneuen.2008.09.004. Epub 2008 Oct 15.

PMID:
18926641

Supplemental Content

Support Center